Yadin Rozov - Net Worth and Insider Trading
Yadin Rozov Net Worth
The estimated net worth of Yadin Rozov is at least $8 Million dollars as of 2024-11-13. Yadin Rozov is the Director of Dave Inc and owns about 96,452 shares of Dave Inc (DAVE) stock worth over $6 Million. Yadin Rozov is the Director of Core Scientific Inc and owns about 80,000 shares of Core Scientific Inc (CORZ) stock worth over $1 Million. Yadin Rozov is also the Director of Oramed Pharmaceuticals Inc and owns about 86,500 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $202,410. Details can be seen in Yadin Rozov's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yadin Rozov has not made any transactions after 2024-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yadin Rozov
Yadin Rozov Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yadin Rozov owns 3 companies in total, including Oramed Pharmaceuticals Inc (ORMP) , Midwest Holding Inc (MDWT) , and VPC Impact Acquisition Holdings III Inc (VPCC.U) .
Click here to see the complete history of Yadin Rozov’s form 4 insider trades.
Insider Ownership Summary of Yadin Rozov
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc | 2023-03-14 | director |
| MDWT | Midwest Holding Inc | 2022-06-14 | director |
| VPCC.U | VPC Impact Acquisition Holdings III Inc | 2023-07-06 | director |
Yadin Rozov Latest Holdings Summary
Yadin Rozov currently owns a total of 3 stocks. Among these stocks, Yadin Rozov owns 96,452 shares of Dave Inc (DAVE) as of March 7, 2024, with a value of $6 Million and a weighting of 79.41%. Yadin Rozov owns 80,000 shares of Core Scientific Inc (CORZ) as of March 15, 2024, with a value of $1 Million and a weighting of 17.93%. Yadin Rozov also owns 86,500 shares of Oramed Pharmaceuticals Inc (ORMP) as of March 14, 2023, with a value of $202,410 and a weighting of 2.66%.
Latest Holdings of Yadin Rozov
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DAVE | Dave Inc | 2024-03-07 | 96,452 | 62.71 | 6,048,505 |
| CORZ | Core Scientific Inc | 2024-03-15 | 80,000 | 17.07 | 1,365,600 |
| ORMP | Oramed Pharmaceuticals Inc | 2023-03-14 | 86,500 | 2.34 | 202,410 |
Holding Weightings of Yadin Rozov
Yadin Rozov Form 4 Trading Tracker
According to the SEC Form 4 filings, Yadin Rozov has made a total of 2 transactions in Dave Inc (DAVE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Dave Inc is the acquisition of 800 shares on March 7, 2024, which cost Yadin Rozov around $29,848.
According to the SEC Form 4 filings, Yadin Rozov has made a total of 1 transactions in Core Scientific Inc (CORZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Core Scientific Inc is the acquisition of 80,000 shares on March 15, 2024, which cost Yadin Rozov around $245,600.
According to the SEC Form 4 filings, Yadin Rozov has made a total of 1 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 70,000 shares on March 14, 2023, which cost Yadin Rozov around $141,400.
Insider Trading History of Yadin Rozov
- 1
Yadin Rozov Trading Performance
GuruFocus tracks the stock performance after each of Yadin Rozov's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yadin Rozov is 131.01%. GuruFocus also compares Yadin Rozov's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yadin Rozov within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yadin Rozov's insider trading performs compared to the benchmark.
Performance of Yadin Rozov
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.66 | | | | | |
| Relative Return to S&P 500(%) | 2.66 | | | | | |
Yadin Rozov Ownership Network
Ownership Network List of Yadin Rozov
Ownership Network Relation of Yadin Rozov
Yadin Rozov Owned Company Details
What does Oramed Pharmaceuticals Inc do?
Who are the key executives at Oramed Pharmaceuticals Inc?
Yadin Rozov is the director of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .
Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oramed Pharmaceuticals Inc Insider Transactions
Yadin Rozov Mailing Address
Above is the net worth, insider trading, and ownership report for Yadin Rozov. You might contact Yadin Rozov via mailing address: 9 Terrace Circle, Armonk Ny 10504.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
